Susanne Schnittger
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia.
Journal: BMC pharmacology & toxicology
Published: January 08, 2020
Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
Journal: European journal of haematology
Published: October 30, 2017
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.
Journal: The American journal of case reports
Published: October 17, 2017
Feasibility of BAALC gene expression for detection of minimal residual disease and risk stratification in normal karyotype acute myeloid leukaemia.
Journal: British journal of haematology
Published: May 06, 2016
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.
Journal: Leukemia
Published: March 12, 2016
BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance.
Journal: British journal of haematology
Published: February 06, 2016
Subtype-specific patterns of molecular mutations in acute myeloid leukemia.
Journal: Leukemia
Published: January 22, 2016
Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.
Journal: Haematologica
Published: October 17, 2015
Array CGH identifies copy number changes in 11% of 520 MDS patients with normal karyotype and uncovers prognostically relevant deletions.
Journal: Leukemia
Published: September 23, 2015
Last Updated: 09/26/2026